ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Re: Intravesical Gemcitabine in Combination with Mitomycin C as Salvage Treatment in Recurrent Non-Muscle-Invasive Bladder Cancer
The Journal of Urology
◽
10.1016/j.juro.2017.01.008
◽
2017
◽
Vol 197
(4)
◽
pp. 1005-1005
Author(s):
Sam S. Chang
Keyword(s):
Bladder Cancer
◽
Mitomycin C
◽
Salvage Treatment
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
Related Documents
Cited By
References
1784 INTRAVESICAL GEMCITABINE IN COMBINATION WITH MITOMYCIN C AS SALVAGE TREATMENT IN RECURRENT NON-MUSCLE INVASIVE BLADDER CANCER
The Journal of Urology
◽
10.1016/j.juro.2013.02.2874
◽
2013
◽
Vol 189
(4S)
◽
Author(s):
Patrick Cockerill
◽
John Knoedler
◽
Robert Karnes
Keyword(s):
Bladder Cancer
◽
Mitomycin C
◽
Salvage Treatment
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
Intravesical gemcitabine in combination with mitomycin C as salvage treatment in recurrent non-muscle-invasive bladder cancer
BJU International
◽
10.1111/bju.13088
◽
2015
◽
Vol 117
(3)
◽
pp. 456-462
◽
Cited By ~ 24
Author(s):
Patrick A. Cockerill
◽
John J. Knoedler
◽
Igor Frank
◽
Robert Tarrell
◽
Robert J. Karnes
Keyword(s):
Bladder Cancer
◽
Mitomycin C
◽
Salvage Treatment
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study
Case Medical Research
◽
10.31525/ct1-nct03844256
◽
2000
◽
Author(s):
Keyword(s):
Bladder Cancer
◽
Mitomycin C
◽
Invasive Bladder Cancer
◽
Curative Treatment
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
◽
Bladder Sparing
Download Full-text
Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with intravesical Mitomycin-C
BMC Urology
◽
10.1186/s12894-018-0408-6
◽
2018
◽
Vol 18
(1)
◽
Cited By ~ 2
Author(s):
Andrew T. Lenis
◽
Kian Asanad
◽
Maher Blaibel
◽
Nicholas M. Donin
◽
Karim Chamie
Keyword(s):
Bladder Cancer
◽
Mitomycin C
◽
Transurethral Resection
◽
Invasive Bladder Cancer
◽
Bladder Tumors
◽
Muscle Invasive Bladder Cancer
◽
Bladder Irrigation
◽
Muscle Invasive
Download Full-text
GSK-J4 combined with mitomycin C as a novel combination therapy for non-muscle invasive bladder cancer
Frontiers in Oncology
◽
10.3389/conf.fonc.2019.01.00010
◽
2019
◽
Vol 9
◽
Author(s):
Anna-Maria Caridis
◽
Callum Perkins
◽
Alessandro Di Maio
◽
Douglas Ward
◽
Udo Oppermann
◽
...
Keyword(s):
Bladder Cancer
◽
Combination Therapy
◽
Mitomycin C
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
Prospective randomized clinical trial of chemohyperthermia with mitomycin-C prior to transurethral resection of the bladder and its relationship with the rate of early recurrence in non-muscle invasive bladder cancer: Intermediate analysis
European Urology Open Science
◽
10.1016/s2666-1683(20)33373-5
◽
2020
◽
Vol 19
◽
pp. e1175-e1176
Author(s):
C. Garcia Alvarez
◽
A.C. Plata Bello
◽
J. Plata Bello
◽
M.A. Tamayo Jover
◽
T. Concepción Masip
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
Randomized Clinical Trial
◽
Mitomycin C
◽
Transurethral Resection
◽
Early Recurrence
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Prospective Randomized Clinical Trial
◽
Muscle Invasive
Download Full-text
Radiation with concurrent radiosensitizing capecitabine tablets and single-dose mitomycin-C for muscle-invasive bladder cancer: A convenient alternative to 5-fluorouracil
Radiotherapy and Oncology
◽
10.1016/j.radonc.2020.07.057
◽
2020
◽
Vol 150
◽
pp. 275-280
◽
Cited By ~ 1
Author(s):
Charlotte S. Voskuilen
◽
Maaike W. van de Kamp
◽
Nannet Schuring
◽
Laura S. Mertens
◽
Arjen Noordzij
◽
...
Keyword(s):
Bladder Cancer
◽
Single Dose
◽
Mitomycin C
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
1669 INTRAVESICAL ADJUVANT ELECTROMOTIVE MITOMYCIN-C IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER A RANDOMIZED CONTROLLED TRIAL
The Journal of Urology
◽
10.1016/j.juro.2012.02.1527
◽
2012
◽
Vol 187
(4S)
◽
Cited By ~ 1
Author(s):
Savino Mauro Di Stasi
◽
Cristian Verri
◽
Emanuele Liberati
◽
Francesco Micali
◽
Francesco Masedu
◽
...
Keyword(s):
Bladder Cancer
◽
Randomized Controlled Trial
◽
Mitomycin C
◽
Controlled Trial
◽
Invasive Bladder Cancer
◽
Intermediate Risk
◽
Muscle Invasive Bladder Cancer
◽
Randomized Controlled
◽
Muscle Invasive
Download Full-text
Cystectomy outcomes in patients who have failed Radiofrequency-induced Thermo-chemotherapeutic Effect Mitomycin-C (RITE-MMC) treatment for high-risk non-muscle invasive bladder cancer (HRNMIBC)–Does it complicate surgery and adversely impact oncological outcome?
Urologic Oncology Seminars and Original Investigations
◽
10.1016/j.urolonc.2020.09.016
◽
2020
◽
Author(s):
Denosshan Sri
◽
Hack Jae Lee
◽
Sarah El-Gemmal
◽
Chris Backhouse
◽
Andrea Tay
◽
...
Keyword(s):
Bladder Cancer
◽
High Risk
◽
Mitomycin C
◽
Oncological Outcome
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Chemotherapeutic Effect
◽
Muscle Invasive
Download Full-text
PD19-07 ONE-YEAR FOLLOW-UP RESULTS AFTER SEQUENTIAL INTRAVESICAL BACILLUS CALMETTE-GUÉRIN AND DEVICE-ASSISTED CHEMO-HYPERTHERMIA (MITOMYCIN C DELIVERED BY THE COMBAT BRS SYSTEM) FOR HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS...A BACILLUS CALMETTE-GUÉRIN-SPARING STRATEGY
The Journal of Urology
◽
10.1016/j.juro.2017.02.880
◽
2017
◽
Vol 197
(4S)
◽
Cited By ~ 1
Author(s):
TR Leyshon Griffiths
◽
William JF Green
◽
Peter T Grice
◽
Jonathan C Goddard
◽
Roger C Kockelbergh
Keyword(s):
Bladder Cancer
◽
High Risk
◽
Cancer Patients
◽
Mitomycin C
◽
Invasive Bladder Cancer
◽
Bacillus Calmette Guerin
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
◽
One Year
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close